Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery.

Background: Continuous intravenous insulin infusion (CII) following coronary artery bypass graft (CABG) surgery reduces postoperative complications and hospitalization duration. Because of limited data evaluating outcomes of CII with revised glycemic targets (110-140 mg/dL) in cardiac surgery, this study compared efficacy and safety of two different CII protocols having revised targets.

Subjects And Methods: This is a retrospective study comparing two different protocols between August 2009 and March 2010.